Prelude Therapeutics secures $60M from Incyte option deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 113.07 -0.2 (0.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $113.27 | 52 Week High | $118.49 | |||
| Open | $113.98 | 52 Week Low | $55.00 | |||
| Day High | $114.57 | P/E | N/A | |||
| Day Low | $112.02 | EPS | $-0.56 | |||
| Volume | 1,580,797 | |||||
| (NASDAQ: PRLD) | Delayed: 3.26 -0.06 (1.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.32 | 52 Week High | $ | |||
| Open | $3.32 | 52 Week Low | $ | |||
| Day High | $3.41 | P/E | N/A | |||
| Day Low | $3.18 | EPS | $ | |||
| Volume | 479,873 | |||||
